mangafodipir

Also found in: Wikipedia.

mangafodipir

[mang″gah-fo´dĭ-pir]

a contrast-enhancing agent used to improve the images obtained in magnetic resonance imaging (MRI) of hepatic lesions; administered intravenously as the trisodium salt.

Mentioned in ?

Teslascan

References in periodicals archive ?

Developmental toxicity of mangafodipir trisodium and manganese chloride in Sprague-Dawley rats.

Critical Windows for Associations between Manganese Exposure during Pregnancy and Size at Birth: A Longitudinal Cohort Study in Wuhan, China

Kim, "MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents," American Journal of Roentgenology, vol.

Detecting GPC3-Expressing Hepatocellular Carcinoma with L5 Peptide-Guided Pretargeting Approach: In Vitro and In Vivo MR Imaging Experiments

Pajaud et al., "Pretreatment with mangafodipir improves liver graft tolerance to ischemia/ reperfusion injury in rat," PloS One, vol.

Overexpression of Brg1 Alleviates Hepatic Ischemia/Reperfusion-Induced Acute Lung Injury through Antioxidative Stress Effects

Detection of Liver Metastases from Adenocarcinoma of the Colon and Pancreas: Comparison of Mangafodipir Trisodium - Enhanced Liver MRI and Whole - Body FDG PET.

ULTRASOUND - GUIDED FINE-NEEDLE ASPIRATION BIOPSY OF METASTATIC LIVER DISEASE: A COMPARATIVE ASSESSMENT OF HISTOLOGICAL AND CYTOLOGICAL TECHNIQUES

PledPharma has restarted recruitment on a clinical trial of mangafodipir in treatment outcomes during angioplasty.

Recipharm supplies CTM to PledPharma

The efficacy of PledOx in reducing serious side-effects of oxaliplatin has been compared with that of another PLED-derivative, mangafodipir, in a preclinical model.

PledPharma unveils positive results of pre-clinical trial of PledOx

One of the earliest HPB agents available was Mangafodipir trisodium.

MR contrast agents: applications in hepatobiliary imaging

Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. J Natl Cancer Inst, 2006, 98, 236-244.

Histological changes in the liver after chemotherapy

5.) Contrast agents used for MR imaging of the liver are gadopentetate dimeglumine (GDTPA) and mangafodipir trisodium.

Viral hepatitis

mangafodipir, manganese dipyridoxyl diphosphate, MnDPDP) or nonchelated forms (e.g.

Manganese-Enhanced [T.sub.1] Mapping in the Myocardium of Normal and Infarcted Hearts

The older of the 2 agents is mangafodipir trisodium (TESLASCAN, GE Healthcare, Chalfont St.

Advances in biliary imaging utilizing MR and CT

The liver-specific contrast agent mangafodipir trisodium (Teslascan, GE Healthcare, Princeton, NJ) is excreted via the biliary system and T1W MRI after injection of this agent may be useful in the diagnosis of a bile leak.